Owner
U
UntitledVerification
Tags
TABLE 1 — HEMOSTASIS (BIG PICTURE FLOW, STEP-BY-STEP)
Stage | Trigger / What starts it | Key molecules / cells | What happens (mechanism) | Outcome / Exam line |
0. Goal | Vascular injury | Platelets + clotting factors + endothelium | Hemostasis = precise, localized clot formation at injury site | Prevent/limit bleeding only at injury |
1. Arteriolar vasoconstriction (Immediate) | Vessel wall injury | Reflex neurogenic mechanisms + endothelin | Transient vasoconstriction reduces blood flow immediately | Must be followed by platelet plug |
2. Primary hemostasis (minutes) | Endothelial disruption → exposes matrix | vWF + collagen + platelets | Adhesion → activation → aggregation → primary platelet plug | Platelet plug forms within minutes |
3. Secondary hemostasis | Injury exposes tissue factor on subendothelial cells (SM cells, fibroblasts) | TF + VII(7) → thrombin → fibrin | Thrombin generation → fibrinogen → insoluble fibrin + platelet activation | Fibrin mesh stabilizes platelet plug |
4. Clot stabilization | Ongoing thrombin + platelet contraction | Polymerized fibrin + platelets | Platelet contraction tightens plug + fibrin polymerizes | Solid permanent hemostatic plug |
5. Counter-regulation / localization | Prevent spread | Endothelium, flow, clearance | Clot limited by endothelial anticoagulants + washout + surface restriction | Prevents systemic thrombosis |
6. Fibrinolysis + resorption | Healing phase | t-PA → plasmin | Fibrin breakdown → clot resorption + tissue repair | Final stage = resorption + repair |
TABLE 2 — PRIMARY HEMOSTASIS (PLATELET PLUG FORMATION: COMPLETE)
Step | Exposure / Trigger | Receptors / mediators | Exact mechanism | Clinical / Exam defects |
1. Adhesion (FIRST) | Endothelium disrupted → collagen + vWF exposed | GpIb on platelets binds vWF (vWF bridges to collagen) | Platelet sticks to damaged wall | vWD (↓/defective vWF) → adhesion failure; Bernard–Soulier (↓GpIb) → cannot adhere |
2. Activation | Adhesion + local signals | Shape change, granule release, TXA₂ synthesis | Platelet becomes “spiky” and pro-active | Impaired activation → weak plug |
3. Shape change | Activation | Cytoskeleton | Disc → spiky sphere with pseudopods (“sea urchin”) | ↑ surface area + bridging |
4. GpIIb/IIIa activation(platelet aggregation) | Activation | GpIIb/IIIa conformational change | Enables binding of fibrinogen | Glanzmann thrombasthenia (GpIIb/IIIa deficiency) → no aggregation |
5. Phospholipid flip | Activation | Phosphatidylserine to outer surface + Ca²⁺ binding | Creates negatively charged surface for coagulation complexes | Links platelets to secondary hemostasis |
6. Secretion (release reaction) | Activation signals | Dense + α granule contents | Recruits more platelets + supports coagulation and repair | Platelet storage disorders → bleeding |
7. Aggregation | Activated platelets nearby | Fibrinogen bridges GpIIb/IIIa between platelets | Primary plug forms | Initial reversible → becomes irreversible with thrombin |
8. Irreversibility & tightening | Thrombin rises | Contractile cytoskeleton + fibrin | Cytoskeletal contraction strengthens plug + fibrin cements | Permanent hemostatic plug |
TABLE 3 — PLATELETS: CORE IDEA + KEY STRUCTURE (ZERO-OMISSION)
Feature | Detail (all included) | Why it matters |
What platelets are | Small, anucleate cell fragments | Fast plug builders |
Origin | From megakaryocytes in bone marrow | Source of platelet production |
Main jobs | (1) Primary hemostatic plug, (2) provide phospholipid surface for coagulation complexes | “Workers + scaffold” |
Key surface receptors | GpIb = adhesion, GpIIb/IIIa = aggregation | Exam-classic |
Mechanical function | Contractile cytoskeleton tightens plug | Stabilizes clot |
Granules | α granules + dense (δ) granules | Stored mediators for activation & repair |
TABLE 4 — PLATELET GRANULES (COMPLETE CONTENTS + MEMORIES)
Granule type | Marker | Contents (zero-omission) | Main roles | Mnemonic |
α-granules | P-selectin (membrane marker) | Fibrinogen, Factor V, vWF, Fibronectin, PF4, PDGF, TGF-β | Coagulation support + wound healing + leukocyte recruitment | P3F3TV = PF4, PDGF, P-selectin + Fibrinogen, Factor V, Fibronectin + TGF-β, vWF |
Dense (δ) granules | — | ADP, ATP, ionized Ca²⁺, serotonin, epinephrine | Rapid platelet activation & recruitment amplification | C-A-S-H = Calcium, ADP/ATP, Serotonin, Hormone (epi) |
TABLE 5 — MAJOR PLATELET ACTIVATORS + DRUG LINK (COMPLETE)
Activator / Factor | Receptor / pathway | Effect | Exam link |
Thrombin | Acts via PAR (protease-activated receptors) | Potent platelet activation + links coagulation ↔ platelets | Thrombin = central regulator |
ADP | Autocrine + paracrine positive feedback | Recruits/activates more platelets | ADPase from endothelium breaks this |
TXA₂ | Synthesized via COX during activation | Platelet aggregation + vasoconstriction | Aspirin irreversibly inhibits COX → ↓TXA₂ → bleeding tendency |
PDGF, TGF-β | Released from α granules | Vessel wall repair, remodeling | Repair link |
TABLE 6 — SECONDARY HEMOSTASIS (TF → THROMBIN → FIBRIN)

Step | Trigger | Key factors | Mechanism | Outcome |
Initiation | Injury exposes tissue factor on subendothelial cells (SM cells, fibroblasts) | TF binds Factor VII | Starts cascade | Thrombin generation begins |
Amplification | Platelet surface available | Complex assembly on phospholipid | Reactions speed up | Clot stays localized |
Thrombin actions | Rising thrombin | Thrombin | Converts fibrinogen → insoluble fibrin + activates platelets | Fibrin mesh stabilizes plug |
Consolidation | Polymerized fibrin + contraction | Factor XIII (later) + platelets | Strong stable clot | Permanent hemostatic plug |
TABLE 7 — “UNIVERSAL REACTION UNIT” OF COAGULATION (YOUR 3-PART RULE)
Component | What it is | Role | If missing |
Enzyme | Activated coagulation factor | Catalyzes step | Reaction fails/slow |
Substrate | Inactive proenzyme factor | Gets activated | No propagation |
Cofactor | Accelerator factor | Increases speed massively | Inefficient clotting |
TABLE 8 — WHY COAGULATION STAYS LOCALIZED (ALL MECHANISMS)

Localizing mechanism | Detail | Exam logic |
Surface restriction | Needs negatively charged phospholipid surface (activated platelets) | Complexes assemble only at injury |
Calcium bridge | Ca²⁺ binds γ-carboxylated glutamate residues | Anchors factors to platelet membrane |
Vitamin K dependency | Needed for γ-carboxylation | Without it factors can’t bind Ca²⁺ |
Flow dilution + clearance | Flow washes factors away; liver clears them | Stops spread |
Endothelial counter-regulation | Intact endothelium is antithrombotic | Key limiter of thrombosis |
TABLE 9 — VITAMIN K FACTORS + WARFARIN (ZERO-OMISSION)
Item | Details |
Vitamin K dependent factors | II, VII, IX, X |
Why K matters | γ-carboxylation → enables Ca²⁺ binding → membrane attachment |
Warfarin (Coumadin) | Antagonizes vitamin K → inhibits II, VII, IX, X |
TABLE 10 — LAB MODEL (PT vs PTT) COMPLETE
Test | Pathway model | Factors tested (complete list) | Reagents added | What’s measured |
PT | Extrinsic | VII, X, V, II (prothrombin), fibrinogen | Tissue factor + phospholipids + Ca²⁺ | Time to fibrin clot |
aPTT | Intrinsic | XII, XI, IX, VIII, X, V, II, fibrinogen | Negatively charged particles (ground glass) + phospholipids + Ca²⁺ | Time to fibrin clot |
TABLE 11 — WHY PT/PTT ≠ REAL LIFE (DEFICIENCY EVIDENCE)
Factor deficiency | Bleeding phenotype | Key implication |
V, VII, VIII, IX, X | Moderate–severe bleeding | These matter most clinically |
Prothrombin (II) | Likely incompatible with life | Central necessity |
XI | Mild bleeding | Christmas disease |
XII | No bleeding; may link to thrombosis | “XII paradox” |
TABLE 12 — TRUE IN-VIVO COAGULATION HIERARCHY (YOUR CLINICAL EVIDENCE VERSION)

Physiologic role | Main complex | What it activates | Why it’s important |
Primary initiator | TF–VIIa | Most important activator of IX | Starts real clotting in vivo |
Central amplifier | IXa + VIIIa | Most important activator of X | Major thrombin burst driver |
Feedback amplification | Thrombin → XI activation | Explains mild bleeding in XI deficiency | Intrinsic supported by thrombin |

TABLE 13 — THROMBIN: MASTER REGULATOR (ALL FUNCTIONS)
Domain | Thrombin action | Details |
Fibrin formation | Converts fibrinogen → fibrin monomers | Monomers polymerize into insoluble fibrils |
Amplifies cascade | Activates V, VIII, XI | Positive feedback |
Stabilization | Activates XIII | XIII covalently crosslinks fibrin |
Platelets | Potent activator via PARs | Links coagulation ↔ platelets |
Inflammation/repair | PARs on inflammatory cells + endothelium | Promotes inflammation, tissue repair, angiogenesis |
Anti-coagulant switch | On normal endothelium thrombin becomes anticoagulant | Prevents clot extension beyond injury |
TABLE 14 — FIBRINOLYSIS (SHUTDOWN SYSTEM: COMPLETE)

Component | Detail | Clinical / Exam |
Central enzyme | Plasmin | Degrades fibrin; interferes with fibrin polymerization |
Marker | Fibrin degradation products incl. D-dimers | Marker of thrombotic states |
Plasmin source | Plasminogen → plasmin | Via activators |
Plasmin generation routes | (1) Factor XII-dependent pathway (2) Plasminogen activators | XII deficiency paradox possibly linked |
Main activator | t-PA | Most important |
t-PA logic | Made mainly by endothelium; most active when bound to fibrin | Fibrinolysis localized to thrombus; t-PA useful drug |
Plasmin control | α₂-plasmin inhibitor rapidly inactivates free plasmin | Prevents excessive fibrinolysis |
TABLE 15 — ENDOTHELIUM: CENTRAL REGULATOR (NORMAL vs INJURED)
State | Behavior | Triggers | Outcome |
Normal endothelium | Anti-thrombotic + anticoagulant + fibrinolytic | Normal physiologic state | Prevents clotting |
Activated/injured endothelium | Pro-thrombotic | Trauma, microbes, hemodynamic stress, pro-inflammatory mediators | Activates platelets + coagulation; thrombus forms/grows |
TABLE 16 — NORMAL ENDOTHELIUM: ANTITHROMBOTIC FUNCTIONS (FULL DETAIL)


Function group | Mechanism / Factor | Exact action | Net effect |
Antiplatelet: physical | Intact surface barrier | Prevents platelet contact with collagen + vWF | Prevents adhesion |
Antiplatelet: chemical | PGI₂ | Vasodilator + inhibits platelet aggregation | ↓ aggregation |
NO | Vasodilator + prevents platelet activation | ↓ activation | |
ADPase | Degrades ADP (platelet activator) | ↓ recruitment | |
Thrombin modulation | Endothelium binds thrombin (via thrombomodulin concept) | Reduces platelet-activating/procoagulant role; promotes protein C activation | Limits clot spread |
Anticoagulant: protein C | Thrombomodulin + EPCR | Activates protein C | Anticoagulant switch |
Protein C + Protein S | Inactivate Va & VIIIa | Slows cascade | |
Anticoagulant: ATIII | Heparin-like molecules enhance antithrombin III | ATIII inhibits thrombin, IXa, Xa, XIa, XIIa | Stops coagulation |
Anticoagulant: TFPI | TFPI (requires protein S as cofactor) | Inhibits TF–VIIa complex | Controls extrinsic initiation |
Fibrinolytic | t-PA | Plasminogen → plasmin (on fibrin) | Breaks down clot |
🔐 FINAL “EXAM SUPER LOCK” (ONE LINE)
Hemostasis is localized because platelet phospholipid + Ca²⁺ + vitamin K factors enable thrombin generation at the injury site, while intact endothelium blocks platelets, activates protein C, boosts ATIII, inhibits TF–VIIa (TFPI), and makes t-PA-driven fibrinolysis occur mainly on fibrin.